Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/50559
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Torres, Fernando | en_US |
dc.contributor.author | Quintana, José | en_US |
dc.contributor.author | Estévez, Francisco | en_US |
dc.contributor.other | Quintana, Jose | - |
dc.contributor.other | Estevez, Francisco | - |
dc.contributor.other | Torres Andon, Fernando | - |
dc.date.accessioned | 2018-11-24T16:59:34Z | - |
dc.date.available | 2018-11-24T16:59:34Z | - |
dc.date.issued | 2010 | en_US |
dc.identifier.issn | 0899-1987 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/50559 | - |
dc.description.abstract | Flavonoids are polyphenolic compounds which display a vast array of biological activities and are promising anticancer agents. In this study we investigated the effect of 5,7,3′-trihydroxy-3,4′-dimethoxyflavone (THDF) on viability of nine human tumor cell lines and found that it was highly cytotoxic against leukemia cells. THDF induced G2-M phase cell-cycle arrest and apoptosis through a caspase-dependent mechanism involving cytochrome c release, processing of multiple caspases (caspase-3, -6, -7, and -9) and cleavage of poly(ADP-ribose) polymerase. Overexpression of the protective mitochondrial proteins Bcl-2 and Bcl-xL conferred partial resistance to THDF-induced apoptosis. This flavonoid induced the phosphorylation of members of the mitogen-activated protein kinases (MAPKs) family and cell death was attenuated by inhibition of c-jun N-terminal kinases/stress-activated protein kinases (JNK/SAPK) and of extracellular signal-regulated kinases (ERK) 1/2. In the present study we report that THDF-induced cell death is mediated by an intrinsic dependent apoptotic event involving mitochondria and MAPKs, and through a mechanism independent of the generation of reactive oxygen species. The results suggest that THDF could be useful in the development of novel anticancer agents. | en_US |
dc.language | eng | en_US |
dc.relation | Desarrollo de Nuevos, Mas Seguros y Mas Efectivos Compuestos Antileucemicos | en_US |
dc.relation | Evaluación de Tdf Como Potencial Fármaco Antitumoral. | en_US |
dc.relation.ispartof | Molecular Carcinogenesis | en_US |
dc.source | Molecular Carcinogenesis[ISSN 0899-1987],v. 49 (5), p. 464-475 (Mayo 2010) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320703 Carcinogénesis | en_US |
dc.subject.other | G(2)-M Phase Arrest | en_US |
dc.subject.other | Differential Regulation | en_US |
dc.subject.other | Signal-Transduction | en_US |
dc.subject.other | Induced Apoptosis | en_US |
dc.subject.other | Mammalian-Cells | en_US |
dc.subject.other | Cancer Cells | en_US |
dc.subject.other | Jnk | en_US |
dc.subject.other | Quercetin | en_US |
dc.subject.other | Kinase | en_US |
dc.subject.other | Inhibition | en_US |
dc.title | 5,7,3′-trihydroxy-3,4′-dimethoxyflavone-induced cell death in human leukemia cells is dependent on caspases and activates the MAPK pathway | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1002/mc.20619 | en_US |
dc.identifier.scopus | 77953033838 | - |
dc.identifier.isi | 000277311800004 | - |
dcterms.isPartOf | Molecular Carcinogenesis | - |
dcterms.source | Molecular Carcinogenesis[ISSN 0899-1987],v. 49 (5), p. 464-475 | - |
dc.contributor.authorscopusid | 55366045300 | - |
dc.contributor.authorscopusid | 8681043500 | - |
dc.contributor.authorscopusid | 7003810011 | - |
dc.description.lastpage | 475 | en_US |
dc.identifier.issue | 5 | - |
dc.description.firstpage | 464 | en_US |
dc.relation.volume | 49 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.identifier.wos | WOS:000277311800004 | - |
dc.contributor.daisngid | 34941095 | - |
dc.contributor.daisngid | 2952604 | - |
dc.contributor.daisngid | 128315 | - |
dc.contributor.daisngid | 384944 | - |
dc.identifier.investigatorRID | K-5709-2014 | - |
dc.identifier.investigatorRID | K-5125-2014 | - |
dc.identifier.investigatorRID | D-5184-2009 | - |
dc.description.numberofpages | 12 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Torres, F | - |
dc.contributor.wosstandard | WOS:Quintana, J | - |
dc.contributor.wosstandard | WOS:Estevez, F | - |
dc.date.coverdate | Mayo 2010 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.jcr | 3,265 | - |
dc.description.jcrq | Q2 | - |
dc.description.scie | SCIE | - |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.orcid | 0000-0001-8225-4538 | - |
crisitem.author.orcid | 0000-0002-9728-2774 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Quintana Aguiar, José Martín | - |
crisitem.author.fullName | Estévez Rosas, Francisco Jesús | - |
crisitem.project.principalinvestigator | Estévez Rosas, Francisco Jesús | - |
crisitem.project.principalinvestigator | Quintana Aguiar, José Martín | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
27
checked on Nov 24, 2024
WEB OF SCIENCETM
Citations
26
checked on Nov 24, 2024
Page view(s)
53
checked on Dec 2, 2023
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.